Back to School: How biopharma can reboot drug development. Access exclusive analysis here

A-002: Phase II started

Anthera began the double-blind, U.S. Phase II PLASMA 2 trial in 120

Read the full 126 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE